Larson S, Campbell N, Huo D, Artz A, Zhang Y, Gajria D, et al.: High Dose Cytarabine (HiDAC) and Mitoxantrone (MITO) Is An Effective Induction Therapy for High-Risk Acute Myeloid Leukemia. Blood 2009, 114:. Abstract No.1048.
Myeloid leukemia in children with Down syndrome (ML-DS) is a unique subtype of acute myeloid leukemia, distinguished by an earlier age of onset (under 4 years of age); somatic mutations of GATA1; hypersensitivity of leukemic blasts to cytarabine and other chemotherapeutic agents; lack of CNS in...
Reid W. Merryman, MD, discusses the impact of adding high-dose cytarabine to bendamustine and rituximab as an induction regimen for patients with mantle cell lymphoma.
网络大剂量阿糖胞苷 网络释义 1. 大剂量阿糖胞苷 ... High-dose immunoglobulin 丙种球蛋白High-dose Cytarabine大剂量阿糖胞苷high-dose methorexate 探讨大剂量甲氨蝶呤 ... dict.youdao.com|基于 1 个网页 例句
To highlight the acceptable results seen after use of low dose cytarabine in elderly patients of acute myeloid leukemia (AML) with comorbidities. This was ... Y Bashir,S Geelani,N Bashir,... - 《South Asian Journal of Cancer》 被引量: 7发表: 2015年 Intensified Cytarabine Dose during Conso...
We describe a 51 year old patient with acute myeloblasts leukemia (AML) who developed pericarditis during treatment with high dose cytarabine. The cytarabine was subsequently stopped and the patient recovered with steriod therapy. The platelet count was carefully monitored, and multiple platelet ...
Dose-dense induction with the S-HAM regimen was compared to standard double induction therapy in adult patients with newly diagnosed acute myeloid leukemia. Patients were centrally randomized (1:1) between S-HAM (2nd chemotherapy cycle starting on day 8
High-dose cytarabine applied during remission induction or as consolidation after attainment of a complete remission has become an established element in the treatment of adults with acute myeloid leukemia. Recent evidence has challenged the need for these exceptionally high-dose levels of cytarabine. In...
Two single-arm, phase 2 trials observed a low CNS relapse rate following high-dose methotrexate-based prophylaxis in young high-risk patients53,54 (table 3). In the first study, high-dose methotrexate and cytarabine delivered after R-CHOEP-14 was associated with a 4·5% CNS relapse rate at...
This report details our preclinical and clinical data in 14 consecutive patients with high-risk remission T-lineage ALL who were prepared for BMT with either high dose cytarabine (ARA-C) in combination with total body irradiation (TBI) or hyperfractionated TBI followed by cyclophosphamide, and who...